Murphy Named As OGD Director At US FDA
As CDER’s Corrigan-Curay Assumes Oversight Of FDA Generics Office
The FDA has announced that agency veteran Iilun Murphy will take over leadership of its Office of Generic Drugs. At the same time, CDER principal deputy center director and chair of the GDUFA steering committee Jacqueline Corrigan-Curay will assume oversight of OGD and the FDA’s generics program.
